Evidence
Trends Mol Med. 2024 Apr 10:S1471-4914(24)00063-7. doi: 10.1016/j.molmed.2024.03.008. Online ahead of print.
ABSTRACT
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive form of pancreatic cancer, known for its challenging diagnosis and limited treatment options. The focus on metabolic reprogramming as a key factor in tumor initiation, progression, and therapy resistance has gained prominence. In this review we focus on the impact of metabolic changes on the interplay among stromal, immune, and tumor cells, as glutamine and branched-chain amino acids (BCAAs) emerge as pivotal players in modulating immune cell functions and tumor growth. We also discuss ongoing clinical trials that explore metabolic modulation for PDAC, targeting mitochondrial metabolism, asparagine and glutamine addiction, and autophagy inhibition. Overcoming challenges in understanding nutrient effects on immune-stromal-tumor interactions holds promise for innovative therapeutic strategies.
PMID:38604929 | DOI:10.1016/j.molmed.2024.03.008
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Exploiting pancreatic cancer metabolism: challenges and opportunities
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
- BCKDK Modification Enhances the Anticancer Efficacy of CAR-T Cells by Reprogramming Branched Chain Amino Acid Metabolism
- Unveiling the altered metabolic pathways induced by nivolumab in non-small cell lung cancer via GC-MS metabolomics approach coupled with multivariate analysis
- CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer
- Emerging measurements for tumor-infiltrating lymphocytes in breast cancer
- BEYOND TRADITIONAL TOOLS: EXPLORING CONVOLUTIONAL NEURAL NETWORKS AS INNOVATIVE PROGNOSTIC MODELS IN PANCREATIC DUCTAL ADENOCARCINOMA
- pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model
- Early detection of pancreatic cancer in the era of precision medicine
- Science around the world
- Enzymatic depletion of circulating glutamine is immunosuppressive in cancers
- Enzymatic depletion of circulating glutamine is immunosuppressive in cancers
- Imaging-based Efficacy Evaluation of Cancer Immunotherapy in Engineered Tumor Platforms and Tumor Organoids
- Myeloid derived suppressor cells and macrophages in regulation of immune response in cancer and tumor progression
- ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation
- Established and emerging treatments for eating disorders
- Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages
- Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/b-catenin pathway and acts as an onco-immunological biomarker
- Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer
- TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level
- Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
- Metabolic reprogramming in the CLL TME; potential for new therapeutic targets
- Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse
- Small-Molecule Inhibitors of TIPE3 Protein Identified through Deep Learning Suppress Cancer Cell Growth In Vitro
- Signal enhancement ratio of multi-phase contrast-enhanced MRI: an imaging biomarker for survival in pancreatic adenocarcinoma
- IFRD1 promotes tumor cells "low-cost" survival under glutamine starvation via inhibiting histone H1.0 nucleophagy
- Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells
- Protocol to quantify immune cell distribution from the vasculature to the glioma microenvironment on sequential immunofluorescence multiplex images
- Protocol to quantify immune cell distribution from the vasculature to the glioma microenvironment on sequential immunofluorescence multiplex images
- Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma
- Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance
- The current sociocultural background of eating disorders
- Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
- Bone Marrow Adipose Tissue
- Softening the tumor matrix through cholesterol depletion breaks the physical barrier for enhanced antitumor therapy
- Brain Metastasis from EGFR-Mutated Non-Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up-Regulates PDL1 and Promotes Immune Escape
- Non-oncogene dependencies: Novel opportunities for cancer therapy
- Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy
- Inflammatory liver diseases and susceptibility to sepsis
- Mesenchymal stem cells as therapeutic vehicles for glioma
- Participation of suicide gene extracellular vesicles in metastasis prevention
- l-Ornithine-l-Aspartate (LOLA) Normalizes Metabolic Parameters in Models of Steatosis, Insulin Resistance and Metabolic Syndrome
- An Update on MR Spectroscopy in Cancer Management: Advances in Instrumentation, Acquisition, and Analysis
- INSPIRED Symposium Part 5: Expanding the Use of CAR T cells in Children and Young Adults
- Multi-omics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients
- Epstein-Barr Virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments
- Is Automatic Tumor Segmentation on Whole-Body 18F-FDG PET Images a Clinical Reality?
- Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)
- CaMKII activity and metabolic imbalance-related neurological diseases: Focus on vascular dysfunction, synaptic plasticity, amyloid beta accumulation, and lipid metabolism
- GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression
- The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance
- Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts
- Enhanced cellular therapy: revolutionizing adoptive cellular therapy
- Histoplasty Modification of the Tumor Microenvironment in a Murine Preclinical Model of Breast Cancer
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging
- Application of 3D, 4D, 5D, and 6D bioprinting in cancer research: what does the future look like?
- Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediators
- Characterization of Polarimetric Properties in Various Brain Tumor Types Using Wide-Field Imaging Mueller Polarimetry
- Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases
- mRNA-responsive two-in-one nanodrug for enhanced anti-tumor chemo-gene therapy
- How Artificial Intelligence Unravels the Complex Web of Cancer Drug Response
- Fasting alleviates metabolic alterations in mice with propionyl-CoA carboxylase deficiency due to Pcca mutation
- Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group
- Single-Cell Data Analysis Reveals Critical Hepatic Cells Subpopulations in the Progression of Non-alcoholic Fatty Liver Disease to Non-Alcoholic Steatohepatitis
Evidence Blueprint
Exploiting pancreatic cancer metabolism: challenges and opportunities
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Exploiting pancreatic cancer metabolism: challenges and opportunities
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
- Metabolic diversity of tumor-infiltrating T cells as target for anti-immune therapeutics
- The regulation of amino acid metabolism in tumor cell death: from the perspective of physiological functions
- BCKDK Modification Enhances the Anticancer Efficacy of CAR-T Cells by Reprogramming Branched Chain Amino Acid Metabolism
- Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages
- Unveiling the altered metabolic pathways induced by nivolumab in non-small cell lung cancer via GC-MS metabolomics approach coupled with multivariate analysis
- Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8+ T cell infiltration in melanoma
- Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors
- Aberrant accumulation of Kras-dependent pervasive transcripts during tumor progression renders cancer cells dependent on PAF1 expression
- CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer
- Emerging measurements for tumor-infiltrating lymphocytes in breast cancer
- BEYOND TRADITIONAL TOOLS: EXPLORING CONVOLUTIONAL NEURAL NETWORKS AS INNOVATIVE PROGNOSTIC MODELS IN PANCREATIC DUCTAL ADENOCARCINOMA
- pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model
- Early detection of pancreatic cancer in the era of precision medicine
- Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer
- Boosting the therapy of glutamine-addiction glioblastoma by combining glutamine metabolism therapy with photo-enhanced chemodynamic therapy
- Science around the world
- Enzymatic depletion of circulating glutamine is immunosuppressive in cancers
- Enzymatic depletion of circulating glutamine is immunosuppressive in cancers
- Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer
- Eating disorders and obesity: bridging clinical, neurobiological, and therapeutic perspectives
- Imaging-based Efficacy Evaluation of Cancer Immunotherapy in Engineered Tumor Platforms and Tumor Organoids
- Myeloid derived suppressor cells and macrophages in regulation of immune response in cancer and tumor progression
- A replicating LCMV-based vaccine for the treatment of solid tumors
- Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome
- Alphaviruses in cancer immunotherapy
- The role of tumor microenvironment on cancer stem cell fate in solid tumors
- Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis
- iPSC-derived models for anorexia nervosa research
- Anorexia nervosa: diagnostic, therapeutic, and risk biomarkers in clinical practice
- ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation
- Established and emerging treatments for eating disorders
- Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages
- d-Amino acids: new clinical pathways for brain diseases
- Organic Selenium induces ferroptosis in pancreatic cancer cells
- Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/b-catenin pathway and acts as an onco-immunological biomarker
- Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer
- SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors
- TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level
- Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
- Metabolic reprogramming in the CLL TME; potential for new therapeutic targets
- Alternative splicing: a bridge connecting NAFLD and HCC
- Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment
- Berberine prevents NAFLD and HCC by modulating metabolic disorders
- Detection of G-Quadruplex DNA Structures in Macrophages
- Tumor-associated astrocytes promote tumor progression of Sonic Hedgehog medulloblastoma by secreting lipocalin-2
- Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse
- Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC
- Small-Molecule Inhibitors of TIPE3 Protein Identified through Deep Learning Suppress Cancer Cell Growth In Vitro
- Signal enhancement ratio of multi-phase contrast-enhanced MRI: an imaging biomarker for survival in pancreatic adenocarcinoma
- IFRD1 promotes tumor cells "low-cost" survival under glutamine starvation via inhibiting histone H1.0 nucleophagy
- Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells
- Protocol to quantify immune cell distribution from the vasculature to the glioma microenvironment on sequential immunofluorescence multiplex images
- Protocol to quantify immune cell distribution from the vasculature to the glioma microenvironment on sequential immunofluorescence multiplex images
- Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma
- Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance
- Immune checkpoint inhibitor treatment of brain metastasis associated with a less invasive growth pattern, higher T-cell infiltration and raised tumor ADC on diffusion weighted MRI
- Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance
- The current sociocultural background of eating disorders
- Cd44v6 acts as a directional responding factor in the process of transcoelomic metastasis from gastric carcinoma to Krukenberg tumor
- Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma
- p53R245W mutation fuels cancer initiation and metastases in NASH-driven liver tumorigenesis
- Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
- Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production